Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Carmot Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011853
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis (NASH), protein-protein interactions (NEMO/IKK) for the treatment of cancer and inflammation; and GLP-1R/GIPR for treating Type 2 diabetes and obesity. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in San Francisco, California, the US.

Carmot Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 10
Licensing Agreements 11
Amgen Enters into Licensing Agreement with Carmot Therapeutics 11
Amgen Expands its Licensing Agreement with Carmot Therapeutics 12
Genentech Enters into Licensing Agreement with Carmot Therapeutics 13
Carmot Therapeutics Inc – Key Competitors 14
Carmot Therapeutics Inc – Key Employees 15
Carmot Therapeutics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Aug 16, 2016: Carmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and Operations 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Carmot Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 10
Amgen Enters into Licensing Agreement with Carmot Therapeutics 11
Amgen Expands its Licensing Agreement with Carmot Therapeutics 12
Genentech Enters into Licensing Agreement with Carmot Therapeutics 13
Carmot Therapeutics Inc, Key Competitors 14
Carmot Therapeutics Inc, Key Employees 15

★海外企業調査レポート[Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Insung Information Co., Ltd. (033230):企業財務及び戦略的SWOT分析
    Summary Insung Information Co., Ltd. (Insung) is an information technology company that provides communication services. The company offers network, storage, unified communications, e-solutions, and healthcare software solutions. It provides united communications products such as IPT and IPCC. Insun …
  • Dynavax Technologies Corporation (DVAX):企業の財務及び戦略的SWOT分析
    Summary Dynavax Technologies Corporation (Dynavax Technologies), formerly Double Helix Corporation is a biopharmaceutical company that provides development and treatment services. The company provides development for the prevention of infectious disease, treatment of autoimmune and inflammatory dise …
  • Koc Holding A.S.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Koc Holding A.S. Mergers and Ac …
  • KAMCO Investment Company K.S.C.P. (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Company K.S.C.P. (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Ahluwalia Contracts (India) Limited:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Ahluwalia Contracts (India) Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetri …
  • Berlin Packaging, LLC.:企業の戦略・SWOT・財務分析
    SummaryBerlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • China Construction Bank Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Construction Bank Corpora …
  • Upsher-Smith Laboratories Inc:企業のM&A・提携動向(医療分野)
    Summary Upsher-Smith Laboratories Inc (Upsher-Smith) is a healthcare solution ppharmaceutical company that develops, manufactures and distributes consumer and central nervous system (CNS) products. The company’s consumer products include restoring body lotion, foot cream, moisturizing body lotion, h …
  • Trivitron Healthcare Pvt., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Trivitron Healthcare Pvt., Ltd. …
  • BRF – Brasil Foods S.A. (formerly Perdigao SA):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BRF - Brasil Foods S.A. (former …
  • Libbs Farmaceutica Ltda-製薬・医療分野:企業M&A・提携分析
    Summary Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which offers biological drug products. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central nervous system transplant. …
  • Takiron Co., Ltd. (4215):企業概要、財務及び戦略的SWOT分析
    Summary Takiron Co., Ltd. (Takiron) manufactures and markets synthetic resins. It manufactures and sells various types of plastics and plastic products. Takiron operates through its four product divisions such as housing environmental materials division, flooring materials division, plastic sheets a …
  • Ziehm Imaging GmbH:企業のM&A・提携動向(医療機器分野)
    Summary Ziehm Imaging GmbH (Ziehm Imaging) specializes in the development, production and global marketing of mobile X-ray based imaging solutions. Its product portfolio includes Vision RFD Hybrid Edition, Vision RFD 3D, Vision R, Vision FD Vario 3D, Vision Vario 3D, Vision FD, Vision, Solo, Solo po …
  • Housing Development Finance Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Housing Development Finance Cor …
  • Paion AG (PA8):企業財務及び戦略的SWOT分析
    Summary Paion AG (PAION) is a specialty pharmaceutical company that focuses on the development and commercialization of drugs which are used in out-patient and hospital-based sedation, critical care and anesthesia services. The company’s lead compound, remimazolam, designed for the treatment of pati …
  • Analog Devices, Inc.:企業のM&A・提携・投資分析
    Analog Devices, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Analog Devices, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Infratil Limited (IFT):企業のM&A・提携動向(エネルギー分野)
    Summary Infratil Limited (Infratil) is an investment company that provides energy, transportation and infrastructure services. The company’s projects include trustpower, lumo energy, infratil energy Australia, direct connect, Perth energy, Z energy, Wellington Airport, NZ bus, snapper, infratil prop …
  • National OilWell Varco, Inc.:企業の戦略・SWOT・財務分析
    National OilWell Varco, Inc. - Strategy, SWOT and Corporate Finance Report Summary National OilWell Varco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GlassHouse Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GlassHouse Technologies, Inc. M …
  • Whitney Holding Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Whitney Holding Corporation Mer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆